Evidence map›Paper›PMID 30175217›Full record

ArticleInternational journal of women's dermatology2018

Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study.

M E Ogunsanya, C M Brown, D Lin, F Imarhia, C Maxey, B F Chong

Open access · goldAbstract read
In one paragraph

Article in International journal of women's dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Outcome Measures in Dystrophic Calcinosis Cutis: A Systematic Review.JID innovations : skin science from molecules to population health · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

M E OgunsanyaCollege of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
C M BrownCollege of Pharmacy, The University of Texas at Austin, Texas.
D LinDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
F ImarhiaCollege of Pharmacy, The University of Texas at Austin, Texas.
C MaxeyCollege of Natural Sciences, The University of Texas at Austin, Austin, Texas.
B F ChongDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
The University of Texas at Austin · USThe University of Texas Southwestern Medical Center · USUniversity of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCutaneous lupus erythematosus (CLE) is a rare dermatologic autoimmune disease marked by photosensitive lesions that can vary in appearance depending on the subtype. The extent to which CLE affects a patient's quality of life (QoL) has not been fully characterized. Focus groups were conducted to explore patients' perspectives of how CLE has affected their lives and to understand the unmet needs in regards to CLE treatment and care.

methodsThis qualitative study involved three focus groups with a total of 19 patients with CLE. A moderator guide containing open-ended questions was used to assess how CLE affects overall QoL. The focus groups were audio-recorded with notetaking. Data were content-analyzed to identify emergent themes.

resultsFour themes emerged as important to patients with CLE: disease sequelae, social interactions, functioning, and unmet needs. Most patients reported decreased QoL due to signs and symptoms such as dyspigmentation and scarring. Having CLE negatively affected patients' mental health and personal relationships and led to negative coping strategies, such as recreational drug use. Issues related to body image were also elicited by patients. Patients cited unmet needs including lack of treatments to improve chronic skin lesions of CLE and inadequate patient education on living with CLE.

conclusionsProviders can look for signs of QoL impairment in patients with CLE by asking questions related to body image, mental health, social isolation, and coping mechanisms. Future QoL measures can include the effect of CLE-specific attributes such as scarring and dyspigmentation to empower patients' voices in determining therapeutic efficacy in future clinical trials. Findings from our study have added a new understanding of daily experiences that were elicited directly from patients with CLE.

Indexed as

burdencutaneous lupus erythematosusfocus groupoutcomesqualitativequality of lifeunmet needs

Identifiers

PMID30175217
PMCPMC6116830
OpenAlexW2796535136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.